Delivery Order SPE2DB22D3019-SPE2DB25FK3YU
Award Date 7/22/25
Potential Completion Date 7/23/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,374.62 to AmerisourceBergen Drug Corp for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg. This non-competitive delivery order, issued on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a firm fixed-price pharmaceutical procurement contract. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $7,776.80 delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of July 23, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's ongoing pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg on July 22, 2025, with a ceiling value of $2,299.76. This competitively awarded, firm fixed-price delivery order is non-set-aside and scheduled for completion by July 23, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Tamsulosin is a medication commonly used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication commonly prescribed for benign prostatic hyperplasia treatment, with a contract value of $1,279.81. The award, issued on July 28, 2025, carries a firm fixed price structure with an ultimate completion date of July 29, 2025. The contract represents a non-set-aside award issued through open competition, reflecting AmerisourceBergen's continued qualification...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Tamsulosin HCL 0.4 mg capsules in a quantity of 500 units, with a ceiling value of $2,217.99. This competitively awarded, non-set-aside contract utilizes firm fixed price terms and carries an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, to provide 4,563,628,875 units of Tamsulosin HCl 0.4 mg capsules. The $3,049.48 order has a completion date of February 13, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division based in Conshohocken, Pennsylvania, is the prime contractor. This delivery order is part of a larger indefinite...
- The U.S. Department of Defense Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $3,868.77 for 1,000 units of Tamsulosin 0.4mg, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order, issued July 25, 2025, carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement through an existing contract vehicle,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for 1,000 units of the medication Tamsulosin Hydrochloride 0.4 mg capsules, with a firm fixed price of $1,230.30 and a period of performance through July 2, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- The Defense Logistics Agency awarded a $8,773.14 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division on September 14, 2023. Under this contract, Amerisourcebergen will provide 1,000 capsules of 0.4 mg Tamsulosin HCl to support the Defense Logistics Agency's medical supply needs. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The contract has an end date of September 15, 2023, indicating delivery of the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,505.61 firm fixed-price delivery order is for 1,000 units of the drug Tamsulosin HCL 0.4 mg capsules. The contract has a completion date of November 7, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle...